Trabecular Bone Matrix Composition in Cynomolgus Monkeys Treated with Sclerostin Antibody

被引：0
|
作者：
Ross, Ryan [1 ]
Ominsky, Michael [2 ]
Acerbo, Alvin [3 ]
Miller, Lisa [3 ]
Sumner, D. Rick [1 ]
机构：
[1] Rush Univ, Med Ctr, Chicago, IL USA
[2] Amgen Inc, Thousand Oaks, CA USA
[3] Brookhaven Natl Lab, Upton, NY 11973 USA
来源：
JOURNAL OF BONE AND MINERAL RESEARCH | 2013年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
SU0060
引用
收藏
页数：2
相关论文
共 50 条
  • [1] INCREASED MODELING-BASED BONE FORMATION AND DECREASED BONE RESORPTION ON ENDOCORTICAL SURFACES IN MALE CYNOMOLGUS MONKEYS TREATED WITH SCLEROSTIN ANTIBODY
    Ominsky, M. S.
    Niu, Q. -T.
    Ke, H. Z.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 67 - 67
  • [2] Two Doses of Sclerostin Antibody in Cynomolgus Monkeys Increases Bone Formation, Bone Mineral Density, and Bone Strength
    Ominsky, Michael S.
    Vlasseros, Fay
    Jolette, Jacquelin
    Smith, Susan Y.
    Stouch, Brian
    Doellgast, George
    Gong, Jianhua
    Gao, Yongming
    Cao, Jin
    Graham, Kevin
    Tipton, Barbara
    Cai, Jill
    Deshpande, Rohini
    Zhou, Lei
    Hale, Michael D.
    Lightwood, Daniel J.
    Henry, Alistair J.
    Popplewell, Andrew G.
    Moore, Adrian R.
    Robinson, Martyn K.
    Lacey, David L.
    Simonet, W. Scott
    Paszty, Chris
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2010, 25 (05) : 948 - 959
  • [3] Sclerostin antibody increased modeling-based bone formation and decreased bone resorption on endocortical surfaces in male cynomolgus monkeys
    Ominsky, M. S.
    Niu, Q. -T.
    Ke, H. Z.
    [J]. BONE, 2012, 50 : S34 - S34
  • [4] Sclerostin antibody treatment enhances BMD and trabecular bone microarchitecture in male rats treated with glucocorticoids
    Achiou, Z.
    Benaitreau, D.
    Pallu, S.
    Dolleans, E.
    Lespessailles, E.
    Ominsky, M.
    Benhamou, C. L.
    [J]. BONE, 2012, 50 : S57 - S58
  • [5] Influence of Ovariectomy on Bone Turnover and Trabecular Bone Mass in Mature Cynomolgus Monkeys
    Iwamoto, Jun
    Seki, Azusa
    Matsuura, Masao
    Sato, Yoshihiro
    Takeda, Tsuyoshi
    Matsumoto, Hideo
    Yeh, James K.
    [J]. YONSEI MEDICAL JOURNAL, 2009, 50 (03) : 358 - 367
  • [6] ILIAC BIOPSY FOR HISTOMORPHOMETRIC ANALYSIS OF TRABECULAR BONE IN CYNOMOLGUS MONKEYS AND BABOONS
    GOODWIN, BT
    JEROME, CP
    [J]. LABORATORY ANIMAL SCIENCE, 1987, 37 (02): : 213 - 216
  • [7] Bone Matrix Quality After Sclerostin Antibody Treatment
    Ross, Ryan D.
    Edwards, Lindsey H.
    Acerbo, Alvin S.
    Ominsky, Michael S.
    Virdi, Amarjit S.
    Sena, Kotaro
    Miller, Lisa M.
    Sumner, D. Rick
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2014, 29 (07) : 1597 - 1607
  • [8] SIX MONTHS OF SCLEROSTIN ANTIBODY TREATMENT IN CYNOMOLGUS MONKEYS: SUSTAINED IMPROVEMENTS IN VERTEBRAL MICROARCHITECTURE AND BONE STRENGTH FOLLOWING A TEMPORAL INCREASE IN CANCELLOUS BONE FORMATION
    Ominsky, M. S.
    Samadfam, R.
    Jolette, J.
    Smith, S. Y.
    Ke, H. Z.
    Boyce, R.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 299 - 299
  • [9] Levormeloxifene prevents increased bone turnover and trabecular bone loss following ovariectomy in cynomolgus monkeys.
    Hotchkiss, CE
    Stavisky, R
    Nowak, J
    Kaplan, J
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 1999, 14 : S408 - S408
  • [10] Denosumab, a fully human RANKL antibody, reduced bone turnover markers and increased trabecular and cortical bone mass, density, and strength in ovariectomized cynomolgus monkeys
    Ominsky, Michael S.
    Stouch, Brian
    Schroeder, Joseph
    Pyrah, Ian
    Stolina, Marina
    Smith, Susan Y.
    Kostenuik, Paul J.
    [J]. BONE, 2011, 49 (02) : 162 - 173
12345